UBS Group’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-365,865
| Closed | -$34.8M | – | 11610 |
|
|
2021
Q4 | $34.8M | Sell |
365,865
-2,793
| -0.8% | -$264K | 0.01% | 1190 |
|
|
2021
Q3 | $34.9M | Buy |
368,658
+368,332
| +112,985% | +$34.8M | 0.01% | 1084 |
|
|
2021
Q2 | $31K | Sell |
326
-4,448
| -93% | -$419K | ﹤0.01% | 6926 |
|
|
2021
Q1 | $445K | Sell |
4,774
-32,074
| -87% | -$3.01M | ﹤0.01% | 4959 |
|
|
2020
Q4 | $3.05M | Buy |
36,848
+14,187
| +63% | +$1.12M | ﹤0.01% | 2961 |
|
|
2020
Q3 | $1.72M | Sell |
22,661
-2,727
| -11% | -$203K | ﹤0.01% | 3194 |
|
|
2020
Q2 | $1.85M | Sell |
25,388
-6,083
| -19% | -$389K | ﹤0.01% | 2947 |
|
|
2020
Q1 | $1.51M | Sell |
31,471
-2,768
| -8% | -$178K | ﹤0.01% | 3022 |
|
|
2019
Q4 | $2.68M | Buy |
34,239
+8,714
| +34% | +$613K | ﹤0.01% | 3252 |
|
|
2019
Q3 | $1.58M | Buy |
25,525
+18,478
| +262% | +$1.23M | ﹤0.01% | 3540 |
|
|
2019
Q2 | $523K | Buy |
7,047
+2,482
| +54% | +$167K | ﹤0.01% | 4264 |
|
|
2019
Q1 | $301K | Sell |
4,565
-9,121
| -67% | -$585K | ﹤0.01% | 4370 |
|
|
2018
Q4 | $779K | Sell |
13,686
-4,145
| -23% | -$256K | ﹤0.01% | 3903 |
|
|
2018
Q3 | $1.28M | Buy |
17,831
+589
| +3% | +$47.4K | ﹤0.01% | 3617 |
|
|
2018
Q2 | $1.66M | Buy |
17,242
+6,017
| +54% | +$577K | ﹤0.01% | 3334 |
|
|
2018
Q1 | $1.2M | Buy |
11,225
+2,043
| +22% | +$205K | ﹤0.01% | 3565 |
|
|
2017
Q4 | $887K | Sell |
9,182
-284
| -3% | -$25.1K | ﹤0.01% | 3875 |
|
|
2017
Q3 | $817K | Buy |
9,466
+4,171
| +79% | +$329K | ﹤0.01% | 3857 |
|
|
2017
Q2 | $386K | Sell |
5,295
-22,303
| -81% | -$1.57M | ﹤0.01% | 4306 |
|
|
2017
Q1 | $1.91M | Sell |
27,598
-21,608
| -44% | -$1.58M | ﹤0.01% | 2988 |
|
|
2016
Q4 | $3.7M | Buy |
49,206
+21,186
| +76% | +$1.36M | ﹤0.01% | 2355 |
|
|
2016
Q3 | $1.51M | Sell |
28,020
-601
| -2% | -$36.2K | ﹤0.01% | 3093 |
|
|
2016
Q2 | $1.88M | Buy |
28,621
+11,912
| +71% | +$802K | ﹤0.01% | 2822 |
|
|
2016
Q1 | $1.14M | Buy |
16,709
+4,348
| +35% | +$262K | ﹤0.01% | 3147 |
|
|
2015
Q4 | $762K | Buy |
12,361
+7,657
| +163% | +$411K | ﹤0.01% | 3624 |
|
|
2015
Q3 | $261K | Buy |
4,704
+1,629
| +53% | +$98.5K | ﹤0.01% | 4426 |
|
|
2015
Q2 | $215K | Buy |
3,075
+2,045
| +199% | +$139K | ﹤0.01% | 4806 |
|
|
2015
Q1 | $73K | Buy |
1,030
+290
| +39% | +$18.3K | ﹤0.01% | 5693 |
|
|
2014
Q4 | $45K | Buy |
+740
| New | +$43.7K | ﹤0.01% | 6627 |
|
UBS Group's MGLN Position: Q1 2022 in Review
UBS Group sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 365,865 shares — an estimated $34.8M sold.
UBS Group first reported a position in MGLN in Q4 2014 and held it in 29 quarters. The position peaked at $34.9M in Q3 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- UBS Group reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 365,865 Magellan Health Services, Inc. shares in Q1 2022, an estimated $34.8M.
- UBS Group first reported a position in Magellan Health Services, Inc. in Q4 2014 and held it in 29 quarters.
- UBS Group's Magellan Health Services, Inc. position peaked at $34.9M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.